Decitabine Improves MMS-induced Retinal Photoreceptor Cell Damage by Targeting DNMT3A and DNMT3B

Overview

Journal Front Mol Neurosci

Specialty Molecular Biology

Date 2023 Jan 27

PMID 36704326

Authors

Yanli Ji

Meng Zhao

Xiaomeng Qiao

Guang-Hua Peng

Affiliations

Soon will be listed here.

Abstract

Introduction: Retinitis pigmentosa (RP) is a group of neurodegenerative retinopathies causing blindness due to progressive and irreversible photoreceptor cell death. The alkylating agent methyl methanesulfonate (MMS) can induce selective photoreceptor cell death, which is used to establish RP animal models. MMS induces DNA base damage by adding alkyl groups to DNA, and epigenetic modifications influence DNA damage response. Here, we aimed to explore the relationship between DNA methylation and DNA damage response in dying photoreceptors of RP.

Methods: The mouse RP model was established by a single intraperitoneal injection of MMS. The retinal structure and function were assessed by H&E, OCT, TUNEL, and ERG at several time points. The expression of DNA methylation regulators was assessed by qPCR and Western blot. DNMT inhibitor 5-aza-dC was applied to inhibit the activity of DNA methyltransferases and improve the retinal photoreceptor damage.

Results: The outer nuclear layer (ONL) and IS/OS layer were significantly thinner and the retinal function was impaired after MMS treatment. The cell death was mainly located in the ONL. The retinal damage induced by MMS was accompanied by hyperexpression of DNMT3A/3B. The application of DNMT inhibitor 5-aza-dC could suppress the expression level of DNMT3A/3B, resulting in the remission of MMS-induced photoreceptor cell damage. The ONL and IS/OS layers were thicker than that of the control group, and the retinal function was partially restored. This protective effect of 5-aza-dC was associated with the down-regulated expression of DNMT3A/3B.

Conclusion: These findings identified a functional role of DNMT3A/3B in MMS-induced photoreceptor cell damage and provided novel evidence to support DNMTs as potential therapeutic targets in retinal degenerative diseases.Graphical Abstract.

Citing Articles

New perspectives on DNA methylation modifications in ocular diseases.

Zong F, Jia D, Huang G, Pan M, Hu H, Song S Int J Ophthalmol. 2025; 18(2):340-350.

PMID: 39967986 PMC: 11754021. DOI: 10.18240/ijo.2025.02.19.

Suppressing DNMT3a Alleviates the Intrinsic Epigenetic Barrier for Optic Nerve Regeneration and Restores Vision in Adult Mice.

Tai W, Cho K, Kriukov E, Ashok A, Wang X, Monavarfeshani A bioRxiv. 2023; .

PMID: 38014168 PMC: 10680854. DOI: 10.1101/2023.11.17.567614.

Heterozygous FOXJ1 Mutations Cause Incomplete Ependymal Cell Differentiation and Communicating Hydrocephalus.

Hou C, Li D, Berry B, Zheng S, Carroll R, Johnson M Cell Mol Neurobiol. 2023; 43(8):4103-4116.

PMID: 37620636 PMC: 10661798. DOI: 10.1007/s10571-023-01398-6.

References

Lai Y, Budworth H, Beaver J, Chan N, Zhang Z, McMurray C . Crosstalk between MSH2-MSH3 and polβ promotes trinucleotide repeat expansion during base excision repair. Nat Commun. 2016; 7:12465. PMC: 4996945. DOI: 10.1038/ncomms12465. View

Reisenhofer M, Balmer J, Zulliger R, Enzmann V . Multiple programmed cell death pathways are involved in N-methyl-N-nitrosourea-induced photoreceptor degeneration. Graefes Arch Clin Exp Ophthalmol. 2015; 253(5):721-31. DOI: 10.1007/s00417-014-2906-x. View

Wang S, Xue Y, Rana P, Hong C, Cepko C . Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa. Proc Natl Acad Sci U S A. 2019; 116(20):10140-10149. PMC: 6525490. DOI: 10.1073/pnas.1901787116. View

Allocca M, Corrigan J, Mazumder A, Fake K, Samson L . Inflammation, necrosis, and the kinase RIP3 are key mediators of AAG-dependent alkylation-induced retinal degeneration. Sci Signal. 2019; 12(568). PMC: 7150588. DOI: 10.1126/scisignal.aau9216. View

Napoli D, Biagioni M, Billeri F, Marco B, Orsini N, Novelli E . Retinal Pigment Epithelium Remodeling in Mouse Models of Retinitis Pigmentosa. Int J Mol Sci. 2021; 22(10). PMC: 8161377. DOI: 10.3390/ijms22105381. View

Schoofs T, Rohde C, Hebestreit K, Klein H, Gollner S, Schulze I . DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding. Blood. 2012; 121(1):178-87. DOI: 10.1182/blood-2012-08-448860. View

Fu D, Calvo J, Samson L . Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer. 2012; 12(2):104-20. PMC: 3586545. DOI: 10.1038/nrc3185. View

Kantarjian H, Issa J . Decitabine dosing schedules. Semin Hematol. 2005; 42(3 Suppl 2):S17-22. DOI: 10.1053/j.seminhematol.2005.05.006. View

Sedgwick B, Bates P, Paik J, Jacobs S, Lindahl T . Repair of alkylated DNA: recent advances. DNA Repair (Amst). 2006; 6(4):429-42. DOI: 10.1016/j.dnarep.2006.10.005. View

10.

Jang K, Do Y, Son D, Son E, Choi J, Kim E . AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. Cell Death Dis. 2017; 8(1):e2526. PMC: 5386356. DOI: 10.1038/cddis.2016.437. View

11.

Weber A, Krawczyk C, Robertson A, Kusnierczyk A, Vagbo C, Schuermann D . Biochemical reconstitution of TET1-TDG-BER-dependent active DNA demethylation reveals a highly coordinated mechanism. Nat Commun. 2016; 7:10806. PMC: 4778062. DOI: 10.1038/ncomms10806. View

12.

Wang S, Du L, Yuan S, Peng G . Complement C3a receptor inactivation attenuates retinal degeneration induced by oxidative damage. Front Neurosci. 2022; 16:951491. PMC: 9469738. DOI: 10.3389/fnins.2022.951491. View

13.

Araujo-Lima C, Christoni L, Justo G, Soeiro M, Aiub C, Felzenszwalb I . Atorvastatin Downregulates Methyl Methanesulfonate and Cyclophosphamide Alkylation-Mediated Cellular and DNA Injuries. Oxid Med Cell Longev. 2018; 2018:7820890. PMC: 5903342. DOI: 10.1155/2018/7820890. View

14.

Lutsenko E, Bhagwat A . Principal causes of hot spots for cytosine to thymine mutations at sites of cytosine methylation in growing cells. A model, its experimental support and implications. Mutat Res. 1999; 437(1):11-20. DOI: 10.1016/s1383-5742(99)00065-4. View

15.

Maiti A, Drohat A . Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J Biol Chem. 2011; 286(41):35334-35338. PMC: 3195571. DOI: 10.1074/jbc.C111.284620. View

16.

Andrabi S, Umanah G, Chang C, Stevens D, Karuppagounder S, Gagne J . Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc Natl Acad Sci U S A. 2014; 111(28):10209-14. PMC: 4104885. DOI: 10.1073/pnas.1405158111. View

17.

Calvo J, Allocca M, Fake K, Muthupalani S, Corrigan J, Bronson R . Parp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent manner. Oncotarget. 2016; 7(29):44950-44965. PMC: 5216697. DOI: 10.18632/oncotarget.10440. View

18.

Flagiello D, Bernardino-Sgherri J, Dutrillaux B . Complex relationships between 5-aza-dC induced DNA demethylation and chromosome compaction at mitosis. Chromosoma. 2002; 111(1):37-44. DOI: 10.1007/s00412-001-0180-2. View

19.

Farinelli P, Perera A, Arango-Gonzalez B, Trifunovic D, Wagner M, Carell T . DNA methylation and differential gene regulation in photoreceptor cell death. Cell Death Dis. 2014; 5:e1558. PMC: 4649831. DOI: 10.1038/cddis.2014.512. View

20.

Sutcu H, Matta E, Ishchenko A . Role of PARP-catalyzed ADP-ribosylation in the Crosstalk Between DNA Strand Breaks and Epigenetic Regulation. J Mol Biol. 2019; 432(6):1769-1791. DOI: 10.1016/j.jmb.2019.12.019. View